- Report
- July 2026
- 267 Pages
Global
From €4484EUR$4,799USD£3,746GBP
- Report
- February 2026
- 100 Pages
Australia, Global
From €4484EUR$4,799USD£3,746GBP
- Report
- November 2026
- 282 Pages
Global
From €5466EUR$5,850USD£4,566GBP
- Report
- February 2026
- 250 Pages
Global
From €4195EUR$4,490USD£3,505GBP
- Report
- September 2026
- 197 Pages
Global
From €3313EUR$3,545USD£2,767GBP
€3681EUR$3,939USD£3,075GBP
- Report
- April 2026
- 358 Pages
Global
From €4195EUR$4,490USD£3,505GBP
- Report
- February 2026
- 250 Pages
Global
From €4195EUR$4,490USD£3,505GBP
- Report
- January 2026
- 185 Pages
Global
From €4205EUR$4,500USD£3,513GBP
- Report
- October 2026
- 209 Pages
Global
From €4484EUR$4,799USD£3,746GBP
- Report
- December 2025
- 341 Pages
Global
From €4484EUR$4,799USD£3,746GBP
- Report
- July 2026
- 294 Pages
Global
From €4484EUR$4,799USD£3,746GBP
- Report
- May 2026
- 241 Pages
Global
From €4484EUR$4,799USD£3,746GBP
- Report
- April 2026
- 271 Pages
Global
From €3878EUR$4,150USD£3,239GBP
- Report
- February 2026
- 250 Pages
Global
From €4195EUR$4,490USD£3,505GBP
- Report
- September 2026
- 120 Pages
Global
From €5560EUR$5,950USD£4,645GBP
- Report
- September 2026
- 308 Pages
Global
From €2336EUR$2,500USD£1,951GBP
- Report
- November 2026
- 166 Pages
Global
From €5466EUR$5,850USD£4,566GBP
- Report
- November 2026
- 278 Pages
Global
From €5466EUR$5,850USD£4,566GBP
- Report
- January 2026
- 182 Pages
Global
From €4205EUR$4,500USD£3,513GBP
- Report
- February 2026
- 250 Pages
Global
From €4195EUR$4,490USD£3,505GBP

The mRNA Therapeutics market is a subset of the larger Genomics market, which focuses on the development of therapeutics based on messenger RNA (mRNA). mRNA is a type of genetic material that is used to produce proteins in cells. mRNA Therapeutics are designed to target specific diseases by delivering mRNA molecules to cells, which can then be used to produce proteins that can treat or prevent the disease. mRNA Therapeutics have the potential to revolutionize the way diseases are treated, as they can be used to target specific diseases without affecting other parts of the body.
The mRNA Therapeutics market is still in its early stages, but is expected to grow rapidly in the coming years. Companies in the market are focused on developing mRNA-based therapeutics for a variety of diseases, including cancer, cardiovascular diseases, and neurological disorders.
Some of the companies in the mRNA Therapeutics market include Moderna, CureVac, Arcturus Therapeutics, and BioNTech. Show Less Read more